Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

114.51 +1.33 (+1.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,635,456
Open 113.45
Bid (Size) 113.30 (2)
Ask (Size) 115.76 (1)
Prev. Close 113.18
Today's Range 113.23 - 114.57
52wk Range 72.43 - 119.96
Shares Outstanding 1,253,809,440
Dividend Yield 2.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GILEAD SCIENCES INC (NASDAQ:GILD) Shows Strong Technical Breakout Potential with High Ratings
Gilead Sciences (GILD) shows strong technical breakout potential with a high Technical Rating (10) and Setup Rating (8), indicating upward momentum and consolidation before a possible breakout. 
Via Chartmill
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?
The upgraded score means Gilead is now outperforming 96% of all stocks in terms of the most important stock-picking criteria. 
Via Investor's Business Daily

Performance

YTD
+24.6%
+24.6%
1 Month
+2.4%
+2.4%
3 Month
+11.4%
+11.4%
6 Month
+16.4%
+16.4%
1 Year
+53.0%
+53.0%

More News

Read More
Pheton Holdings Dismisses Rumors Of Acquisition By Gilead, But Retail’s Extremely Optimistic
Via Stocktwits
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Chinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers'
Via Benzinga
Price Over Earnings Overview: Gilead Sciences
Via Benzinga
Why Gilead Sciences Stock Slipped Today
Via The Motley Fool
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive
Via Stocktwits
Visa, Disney, Blackstone And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
Why Gilead Sciences (GILD) Stock Is Up Today
Via StockStory
Topics Stocks World Trade
Why Gilead Sciences Stock Just Popped
Via The Motley Fool
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
Via Benzinga
This Gilead Sciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
Via Stocktwits
Topics Workforce
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
From Gilead Sciences, Inc.
Via Business Wire
1 Value Stock Worth Your Attention and 2 Facing Headwinds
Via StockStory
Topics Supply Chain
Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year
Via The Motley Fool
Topics Regulatory Compliance
Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know
Via StockStory
Topics Stocks World Trade
NAFA Publishes New Fleet Safety Guidebook Aimed  at Developing Safety-First Culture in all Organizations
Via News Direct
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
From Pomerantz LLP
Via GlobeNewswire
2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm
Via StockStory
Topics Supply Chain
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
From Pomerantz LLP
Via GlobeNewswire
Expanding the Preventive Care Frontier: Dr. Reddy’s Launches Sanofi’s Beyfortus® in India
Via AB Newswire
Topics Death
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 114.51
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 08/04/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 143.57B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 144B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.